RK
Raj Kumar Khemani
About Raj Kumar Khemani
Data last updated:
Raj Kumar Khemani is a Whole-Time Director at Kci Medical India Private Limited (since 2025) and Director at Trimodal Softech Solutions Private Limited (since 2025). The companies operate in Financial Services, Information Technology and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹190 Cr; the largest is Kci Medical India Private Limited at ₹136 Cr (FY 2025). Earlier, Raj Kumar Khemani was a Director at Glaxosmithkline Consumer Private Limited (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kci Medical India Private Limited U51397DL2010FTC207599 | Whole-Time Director | 29 Sep 2025 | 2010 | ₹136 Cr (FY 2025) | Active |
 Trimodal Softech Solutions Private Limited U72900KA2019PTC120334 | Director | 17 Apr 2025 | 2019 | ₹53.66 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glaxosmithkline Consumer Private Limited U24232PB2014FTC039082 | Director | 22 Jul 2022 | 2014 | ₹675 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Raj Kumar Khemani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Inavolu Venkata Jagadish | 10198591 | Kci Medical India Private Limited | Director |
| Kuppanda Ayappa Appiah | 07939378 | Kci Medical India Private Limited , Trimodal Softech Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raj Kumar Khemani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raj Kumar Khemani
Raj Kumar Khemani currently holds 2 directorships: Kci Medical India Private Limited (Whole-Time Director, since 29 Sep 2025, revenue ₹136 Cr (FY 2025)); Trimodal Softech Solutions Private Limited (Director, since 17 Apr 2025, revenue ₹53.66 Cr (FY 2025)).
Raj Kumar Khemani was first appointed on 22 Jul 2022 as Director at Glaxosmithkline Consumer Private Limited. The most recent appointment on record is 29 Sep 2025 at Kci Medical India Private Limited.
The 2 current companies of Raj Kumar Khemani that report revenue have a combined latest revenue of ₹190 Cr: Kci Medical India Private Limited ₹136 Cr (FY 2025); Trimodal Softech Solutions Private Limited ₹53.66 Cr (FY 2025).
Raj Kumar Khemani held 1 earlier board appointment: Glaxosmithkline Consumer Private Limited (Director, 22 Jul 2022 to 25 Feb 2025).
The current boards of Raj Kumar Khemani's companies include Inavolu Venkata Jagadish (Kci Medical India Private Limited), Kuppanda Ayappa Appiah (Kci Medical India Private Limited).